Drugs Controlling Proteinuria of Patients with Alport Syndrome

Jian-Guo Li,Jie Ding,Fang Wang,Hong-Wen Zhang
DOI: https://doi.org/10.1007/s12519-009-0059-5
2009-01-01
World Journal of Pediatrics
Abstract:BACKGROUND:Proteinuria is one of the risk factors for the progression of renal diseases including Alport syndrome (AS), a hereditary glomerular renal disease. This study aimed to evaluate the efficacy of angiotensin converting enzyme inhibitors (ACEIs) and/or tripterygium, a Chinese herbal medicine widely used in Chinese patients with hematuria and proteinuria, on proteinuria in patients with AS.METHODS:Twenty-nine children were enrolled into this retrospective study. Patients were divided into 3 therapy groups: ACEI group, tripterygium group, and ACEI plus tripterygium group.RESULTS:In the 29 children, 23 were male and 6 female. In the ACEI group and the tripterygium group, the effective rate was 87.5% and 25.0%, respectively and in the ACEI plus tripterygium group was 42.9%.CONCLUSIONS:ACEI is effective in controlling proteinuria of AS patients. Tripterygium should be carefully administered in controlling proteinuria of AS patients.
What problem does this paper attempt to address?